MARKET

RGEN

RGEN

Repligen
NASDAQ
165.21
-0.52
-0.31%
Opening 11:34 12/30 EST
OPEN
164.93
PREV CLOSE
165.73
HIGH
166.05
LOW
162.02
VOLUME
53.89K
TURNOVER
--
52 WEEK HIGH
182.52
52 WEEK LOW
102.97
MARKET CAP
9.30B
P/E (TTM)
6403.59
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at RGEN last week (1222-1226)?
Weekly Report · 1d ago
Is Repligen (RGEN) Quietly Recasting Its Gene Therapy Moat With New HiPer Viral Vector Resins?
Simply Wall St · 5d ago
Adaptive Biotechnologies is the top performing life sciences tools and services stock YTD
Seeking Alpha · 12/23 05:06
3 Stocks Estimated To Be Trading Below Their Intrinsic Value In December 2025
Simply Wall St · 12/22 17:08
Weekly Report: what happened at RGEN last week (1215-1219)?
Weekly Report · 12/22 10:09
Repligen (RGEN): Assessing Valuation After New Chromatography Resins Expand Its Gene Therapy Toolkit
Simply Wall St · 12/19 05:21
Insider Move at Repligen Sparks Fresh Buzz on Wall Street
TipRanks · 12/19 02:06
Repligen Director Karen A. Dawes Reports Sale of Common Shares
Reuters · 12/18 21:31
More
About RGEN
Repligen Corporation is a global life sciences company that develops and commercializes bioprocessing technologies and systems. Its focus areas are Filtration and Fluid Management, Chromatography, Process Analytics and Proteins. Its filtration products are used in process development and process scale (clinical and commercial) production. Its XCell ATF systems are used in upstream perfusion (continuous) and N-1 (intensified fed-batch or hybrid perfusion) cell culture processing. Its chromatography franchise includes several products used in downstream purification, development, manufacturing and quality control of biological drugs. Its process analytics products complement and support its filtration, chromatography and protein franchises. Its TangenX product portfolio includes flat sheet (FS) tangential flow filtration (TFF) cassettes used primarily in downstream and ultrafiltration processes. Its desktop portfolio includes MAVERICK and MAVEN, REBEL, and ZipChip.

Webull offers Repligen Corp stock information, including NASDAQ: RGEN real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, RGEN stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading RGEN stock methods without spending real money on the virtual paper trading platform.